Showing results (131-140 of 183) with videos related to
Sort By:
Pageof 19
Epilepsy Research|August 5, 2000
Comparison between the QOLIE-31 and derived QOLIE-10 in a clinical trial of levetiracetamJ A Cramer, C Arrigo, G Van Hammée, et al.Psychiatry Research|July 1, 1992
Dopaminergic responsivity during cocaine abstinence: a pilot studyC J McDougle, L H Price, J M Palumbo, et al.Archives of General Psychiatry|June 1, 1983
Imipramine as treatment for depression in addictsH D Kleber, M M Weissman, B J Rounsaville, et al.Archives of General Psychiatry|April 1, 1985
Clonidine in outpatient detoxification from methadone maintenanceH D Kleber, C E Riordan, B Rounsaville, et al.Drug and Alcohol Dependence|February 1, 1990
Opioid antagonist challenges in buprenorphine maintained patientsT R Kosten, J H Krystal, D S Charney, et al.Therapeutic Drug Monitoring|January 1, 1986
Variable free and total valproic acid concentrations in sole- and multi-drug therapyJ A Cramer, R H Mattson, D M Bennett, et al.International Journal of Clinical Practice|November 7, 2007
The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a reviewJ A Cramer, A Benedict, N Muszbek, et al.Annals of Neurology|January 1, 1978
Valproic acid in epilepsy: clinical and pharmacological effectsR H Mattson, J A Cramer, P D Williamson, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 20, 2007
A systematic review of persistence and compliance with bisphosphonates for osteoporosisJ A Cramer, D T Gold, S L Silverman, et al.Epilepsia|July 1, 1986
Behavioral toxicity associated with antiepileptic drugs: concepts and methods of assessmentR A Novelly, M M Schwartz, R H Mattson, et al.Pageof 19